Testing effectiveness (Phase 2)Ended earlyNCT04048876
What this trial is testing
Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis
Who this might be right for
Non-alcoholic Fatty Liver DiseaseLiver Cirrhosis
Celgene 56